U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C16H11ClN4O
Molecular Weight 310.738
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 1-OXOESTAZOLAM

SMILES

ClC1=CC=C2N3C(=O)NN=C3CN=C(C4=CC=CC=C4)C2=C1

InChI

InChIKey=BKXMIHOSZZYXDH-UHFFFAOYSA-N
InChI=1S/C16H11ClN4O/c17-11-6-7-13-12(8-11)15(10-4-2-1-3-5-10)18-9-14-19-20-16(22)21(13)14/h1-8H,9H2,(H,20,22)

HIDE SMILES / InChI

Molecular Formula C16H11ClN4O
Molecular Weight 310.738
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Tue Apr 01 21:21:16 GMT 2025
Edited
by admin
on Tue Apr 01 21:21:16 GMT 2025
Record UNII
G4JQ545FZL
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
1H-S-TRIAZOLO(4,3-A)(1,4)BENZODIAZEPIN-1-ONE, 8-CHLORO-2,4-DIHYDRO-6-PHENYL-
Preferred Name English
1-OXOESTAZOLAM
Common Name English
8-CHLORO-2,4-DIHYDRO-6-PHENYL-1H-(1,2,4)TRIAZOLO(4,3-A)(1,4)BENZODIAZEPIN-1-ONE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID10185190
Created by admin on Tue Apr 01 21:21:16 GMT 2025 , Edited by admin on Tue Apr 01 21:21:16 GMT 2025
PRIMARY
PUBCHEM
3082325
Created by admin on Tue Apr 01 21:21:16 GMT 2025 , Edited by admin on Tue Apr 01 21:21:16 GMT 2025
PRIMARY
FDA UNII
G4JQ545FZL
Created by admin on Tue Apr 01 21:21:16 GMT 2025 , Edited by admin on Tue Apr 01 21:21:16 GMT 2025
PRIMARY
CAS
31262-82-5
Created by admin on Tue Apr 01 21:21:16 GMT 2025 , Edited by admin on Tue Apr 01 21:21:16 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> METABOLITE LESS ACTIVE
m. 1-0x0-estazolam was about five times less effective than the parent drug in terms of brain concn. necessary to disrupt rota-rod performance but only twice in respect to the anticonvulsant activity.